<?xml version="1.0" encoding="UTF-8"?>
<akn:akomaNtoso xmlns:akn="http://docs.oasis-open.org/legaldocml/ns/akn/3.0"><akn:act><akn:meta><akn:identification source="#cosilico"><akn:FRBRWork prescriptive="true" authoritative="true"><akn:FRBRuri value="/akn/us/usc/42/284f" /><akn:FRBRdate date="2025-12-31" name="retrieval" /><akn:FRBRauthor href="#us-congress" /><akn:FRBRcountry value="us" /></akn:FRBRWork><akn:FRBRExpression><akn:FRBRuri value="/akn/us/usc/42/284f/eng@2025" /><akn:FRBRdate date="2025-12-31" /><akn:FRBRauthor href="#cosilico" /><akn:FRBRlanguage language="en" /></akn:FRBRExpression><akn:FRBRManifestation><akn:FRBRuri value="/akn/us/usc/42/284f/eng@2025/main.xml" /><akn:FRBRdate date="2025-12-31" /><akn:FRBRauthor href="#cosilico" /></akn:FRBRManifestation></akn:identification></akn:meta><akn:body><akn:section eId="sec_284f"><akn:num>284f</akn:num><akn:heading>Parkinson’s disease</akn:heading><akn:content><akn:p>§ 284f. Parkinson’s disease(a) In generalThe Director of NIH shall establish a program for the conduct and support of research and training with respect to Parkinson’s disease (subject to the extent of amounts appropriated to carry out this section).


(b) Inter-institute coordination(1) In generalThe Director of NIH shall provide for the coordination of the program established under subsection (a) among all of the national research institutes conducting Parkinson’s disease research.


(2) ConferenceCoordination under paragraph (1) shall include the convening of a research planning conference not less frequently than once every 2 years. Each such conference shall prepare and submit to the Committee on Appropriations and the Committee on Labor and Human Resources of the Senate and the Committee on Appropriations and the Committee on Commerce of the House of Representatives a report concerning the conference.



(c) Morris K. Udall research centers(1) In generalThe Director of NIH is authorized to award Core Center Grants to encourage the development of innovative multidisciplinary research and provide training concerning Parkinson’s disease. The Director is authorized to award not more than 10 Core Center Grants and designate each center funded under such grants as a Morris K. Udall Center for Research on Parkinson’s Disease.


(2) Requirements(A) In generalWith respect to Parkinson’s disease, each center assisted under this subsection shall—(i) use the facilities of a single institution or a consortium of cooperating institutions, and meet such qualifications as may be prescribed by the Director of the NIH; and

(ii) conduct basic and clinical research.


(B) Discretionary requirementsWith respect to Parkinson’s disease, each center assisted under this subsection may—(i) conduct training programs for scientists and health professionals;

(ii) conduct programs to provide information and continuing education to health professionals;

(iii) conduct programs for the dis</akn:p></akn:content><akn:subsection eId="subsec_284f_a"><akn:num>(a)</akn:num><akn:heading>In general</akn:heading><akn:content><akn:p>(a) In general The Director of NIH shall establish a program for the conduct and support of research and training with respect to Parkinson’s disease (subject to the extent of amounts appropriated to carry out this section).</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_284f_b"><akn:num>(b)</akn:num><akn:heading>Inter-institute coordination</akn:heading><akn:content><akn:p>(b) Inter-institute coordination</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_284f_c"><akn:num>(c)</akn:num><akn:heading>Morris K. Udall research centers</akn:heading><akn:content><akn:p>(c) Morris K. Udall research centers</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_284f_d"><akn:num>(d)</akn:num><akn:heading>Morris K. Udall Awards for Excellence in Parkinson’s Disease Research</akn:heading><akn:content><akn:p>(d) Morris K. Udall Awards for Excellence in Parkinson’s Disease Research The Director of NIH is authorized to establish a grant program to support investigators with a proven record of excellence and innovation in Parkinson’s disease research and who demonstrate potential for significant future breakthroughs in the understanding of the pathogensis,11 So in original. Probably should be “pathogenesis,”. diagnosis, and treatment of Parkinson’s disease. Grants under this subsection shall be available for a period of not to exceed 5 years.</akn:p></akn:content></akn:subsection></akn:section></akn:body></akn:act></akn:akomaNtoso>